公司概覽
業務類別 --
業務概覽 Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
公司地址 Grenzacherstrasse 124, Basel, CHE, 4070
電話號碼 +41 616881111
傳真號碼 +41 616910014
公司網頁 https://www.roche.com
員工數量 112774
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Professor Dr. Richard P. Lifton Independent Director 27/01/2026
Dr. Jorg Duschmale Independent Director 27/01/2026
Dr. Claudia Sussmuth Dyckerhoff, PhD Independent Director 27/01/2026
Dr. Mark Schneider, PhD Independent Director 27/01/2026
Professor Dr. Akiko Iwasaki Independent Director 27/01/2026
Ms. Anita Hauser Independent Director 27/01/2026
Dr. Severin Schwan Chairman of the Board 27/01/2026
Mr. Andre S. Hoffmann Vice Chairman of the Board 27/01/2026
Mr. Patrick Frost Independent Director 27/01/2026
Dr. Jemilah Mahmood Independent Director 27/01/2026
 
所屬ETF (更新日期: 07/03/2026 02:20)
代號 名稱 佔比% 持有日期
HDAWXtrackers MSCI All WldexUSHiDivYldEqETF<0.000001%23/07/2024
HEFAiShares Currency Hedged MSCI EAFE ETF<0.000001%28/02/2026
IHDGWisdomTree Intl Hdgd Qual Div Gr ETF<0.000001%23/10/2025
IMFLInvesco Intl Dev Dynmc Mltfctr ETF<0.000001%07/11/2025
IMTMiShares MSCI Intl Momentum Factor ETF<0.000001%26/08/2025
IQDGWisdomTree International Qual Div Gr ETF<0.000001%23/10/2025
QLVDFlexShares Dev Mks ex-US Qual Lw Vol ETF<0.000001%02/06/2025
  1    2    3    4   5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.